drugset / Trial / NCT03000218
Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems
RandomizedParallel-groupOpen-labelTreatment
Summary
A clinical study to evaluate pharmacokinetics, metabolomics and biomarker in subjects who are overweight and have liver problems after ursodeoxycholic acid multiple administration
Timeline
- Start
- 2016-08
- Primary completion
- 2017-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 500 mg | — |
| Subject | Ursodeoxycholic Acid | Small molecule | 300 mg | — |